Furthermore, Colombo et al., using modified adenocarcinoma cells that produced granulocyte-colony-stimulating factor (G-CSF), reached a conclusion that neutrophils are recruited by G-CSF into tumors, where they come in contact with tumor cells, inhibiting tumor development [40]. Here, CSF3 is linked to adenocarcinoma.